معرفی
Dr. Jay Jha is a Senior Research Fellow at Monash University's Department of Diabetes within the School of Translational Medicine. He specializes in discovering novel therapeutic targets and biomarkers for diabetes and kidney diseases, with a focus on oxidative stress, fibrosis, and inflammatory pathways. His work includes advancing translational medicine through projects like NOX5 inhibition and kidney organoid research.
- Education: PhD in Diabetes (Monash University, 2014)
- Affiliations: German Diabetes Centre (visiting scholar 2022), Baker Heart and Diabetes Institute (2015–2017)
Research Interests: NOX5 as a therapeutic target, biomarkers for diabetic kidney disease, and the oxidative stress-inflammation-fibrosis axis. Key contributions include identifying NOX5 as a biomarker and inhibitor target, with over 3,500 citations and an H-index of 24.
Awards: NHMRC Peter Doherty Fellowship (2017), FMNHS Future Leader Postdoctoral Fellowship (2025), and multiple Diabetes Australia grants (2020–2024).
- Grants: $2.1M+ secured from competitive funding bodies
- Publications: 51+ peer-reviewed articles in journals like Diabetologia and Antioxidants
Labs/Teams: Leads the Jandeleit-Dahm Group at Monash, collaborating internationally on projects like translational kidney fibrosis imaging and NOX5-targeted therapies.
